Literature DB >> 9159401

Antibiotic-induced endotoxin release from bacteria and its clinical significance.

T Kirikae1, M Nakano, D C Morrison.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9159401     DOI： 10.1111/j.1348-0421.1997.tb01203.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN： 0385-5600            Impact factor:   1.955


× No keyword cloud information.
  14 in total

1.  Bacterial cell wall compounds as promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyamines.

Authors:  Guillermo Martínez de Tejada; Susana Sánchez-Gómez; Iosu Rázquin-Olazaran; Ina Kowalski; Yani Kaconis; Lena Heinbockel; Jörg Andrä; Tobias Schürholz; Mathias Hornef; Aline Dupont; Patrick Garidel; Karl Lohner; Thomas Gutsmann; Sunil A David; Klaus Brandenburg
Journal:  Curr Drug Targets       Date:  2012-08       Impact factor: 3.465

2.  Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria.

Authors:  Ryan D Heselpoth; Chad W Euler; Raymond Schuch; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

3.  Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia.

Authors:  T Kirikae; M Hirata; H Yamasu; F Kirikae; H Tamura; F Kayama; K Nakatsuka; T Yokochi; M Nakano
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 4.  Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.

Authors:  Roland Nau; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

5.  Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1 beta.

Authors:  K Kishi; K Hirai; K Hiramatsu; T Yamasaki; M Nasu
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

6.  Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats.

Authors:  Koji Fukumoto; Isao Nagaoka; Atsuyuki Yamataka; Hiroyuki Kobayashi; Toshihiro Yanai; Yoshifumi Kato; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

Review 7.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

Review 8.  ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes.

Authors:  Anna V Piterina; Aidan J Cloonan; Claire L Meaney; Laura M Davis; Anthony Callanan; Michael T Walsh; Tim M McGloughlin
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

9.  Inhibition of lethal inflammatory responses through the targeting of membrane-associated Toll-like receptor 4 signaling complexes with a Smad6-derived peptide.

Authors:  Youn Sook Lee; Jin Seok Park; Su Myung Jung; Sang-Doo Kim; Jun Hwan Kim; Jae Young Lee; Kyeong Cheon Jung; Mizuko Mamura; Sangho Lee; Seong-Jin Kim; Yoe-Sik Bae; Seok Hee Park
Journal:  EMBO Mol Med       Date:  2015-05       Impact factor: 12.137

Review 10.  Lessons from bacteriophages part 2: A saga of scientific breakthroughs and prospects for their use in human health.

Authors:  Kunica Asija; Carolyn M Teschke
Journal:  PLoS Pathog       Date:  2018-05-17       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.